The FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related semaglutide-based drugs, Ozempic and Wegovy – since 2022 amid unprecedented demand.
The end of a shortage of popular weight-loss drugs may mean many people lose access to them
Related Posts
-
Check your tickets! Powerball numbers drawn for $820M jackpot
Feeling lucky? Here are Saturday’s Powerball numbers.
-
Teddy bear’s hit the ice for Salvation Army annual Christmas toy drive
DES MOINES, Iowa — Hundreds of teddy bear’s flew into the rink Saturday night for…
-
Heiden scores 17, No. 12 Iowa women beat Rutgers 79-36 in Big Ten opener
The Hawkeyes have won seven straight against Rutgers and are 15-3 in the series.
-
News We Love: Family decorates home with 25,000 Christmas lights
Ashley and Jason Garneau have been nicknamed the “Griswolds” of their small neighborhood in Swanton,…
Leave a Reply